Azacitidine is the generic name of the medication and is its international nonproprietary name. Azacitidine is marketed under the brand name Azatend among others.
Azacitidine, sold under the brand name Azatend among others, is a medication used for the treatment of myelodysplastic syndrome, myeloid leukemia, and juvenile myelomonocytic leukemia. It is a chemical analog of cytidine, a nucleoside in DNA and RNA. Azacitidine and its deoxy derivative, decitabine (also known as 5-aza-2Â-deoxycytidine) were first synthesized in Czechoslovakia as potential chemotherapeutic agents for cancer.
Azacitidine is indicated for the treatment of myelodysplastic syndrome, for which it received approval by the U.S. Food and Drug Administration (FDA) on 19 May 2004. Azacitidine is also indicated for the treatment of myeloid leukemia and juvenile myelomonocytic leukemia. The combination of azacitidine and venetoclax is also approved for AML.

Price:
Price 32.0 INR / Pack
Minimum Order Quantity : 100 Packs
Dosage Guidelines : As per doctor suggestion
Pacakaging (Quantity Per Box) : 5x10 Tablets
Physical Form : Tablets
Drug Type : General Medicines
Price 800.0 INR / Pack
Minimum Order Quantity : 100 Packs
Dosage Guidelines : As per doctor suggestion
Pacakaging (Quantity Per Box) : 60 Tablets
Physical Form : Tablets
Drug Type : General Medicines
Price 2100.0 INR / Pack
Minimum Order Quantity : 100 Packs
Dosage Guidelines : As per doctor suggestion
Pacakaging (Quantity Per Box) : 1*60 Tablet
Physical Form : Tablets
Drug Type : General Medicines
Price 1300.0 INR / Pack
Minimum Order Quantity : 100 Packs
Dosage Guidelines : As per doctor suggestion
Pacakaging (Quantity Per Box) : 4x7 Tablet
Physical Form : Tablets
Drug Type : General Medicines